Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × Radiation × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 8 Brain Neoplasms 6 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Intraductal, Noninfiltrating 4 Uterine Cervical Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Glioblastoma 3 Endometrial Neoplasms 3 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Glioma 2 Carcinoma, Ductal, Breast 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tonsillar Neoplasms 1 Symptomatic Osseous Bone Lesions From Any Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Recurrence 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 24 Rituximab 16 fludarabine phosphate 13 Radiotherapy 12 Vincristine 10 Peripheral Blood Stem Cell Transplantation 10 Melphalan 10 Filgrastim 10 Cytarabine 10 Methotrexate 9 Exercise 9 Doxorubicin 9 Cyclosporine 9 Busulfan 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisone 6 Prednisolone 6 Methods 6 Etoposide 6 Educational Status 6 Early Intervention, Educational 6 Blood Specimen Collection 6 Palliative Care 5 Leucovorin 5 fludarabine 4 Geriatric Assessment 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00141648 2009-10-01

Chemotherapy and Radiotherapy for Osteolymphoma

Trans Tasman Radiation Oncology Group

Phase NA Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡